Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human ADRA1D Stable Cell Line

    [CAT#: S01YF-0923-PY7]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    ADRA1D
    Target Family
    Adrenergic Family
    Target Protein Species
    Mouse
    Host Cell Type
    C2;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Digestive and Renal Research
    Related Diseases
    Ureterolithiasis;Perianal Hematoma
    Gene ID
    Mouse: 11550

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The α1D-adrenergic receptor, ADRA1D, has been the subject of numerous scientific investigations, particularly in relation to hypertension and cancer progression. One notable study found that QiShenYiQi, a traditional medicine, ameliorated salt-induced hypertensive nephropathy by balancing the expression of ADRA1D, suggesting a potential therapeutic role in hypertension management. Furthermore, ADRA1D has been implicated in the progression of cutaneous melanoma. Overexpression of ADRA1D inhibited the invasion and proliferation of melanoma cells, reducing angiogenesis and thereby attenuating the growth and metastatic potential of the cancer. Additionally, research on skeletal myoblasts has shown that ADRA1D plays a crucial role in muscle cell survival, emphasizing its significance in muscle regeneration. These findings underscore the diverse roles of ADRA1D in various physiological and pathological processes, highlighting its importance in scientific research.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human ADRA1D Stable Cell Line (S01YF-0923-PY7). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Shirley (Verified Customer)

    Are there any known diseases or conditions associated with ADRA1D? Oct 14 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Yes, ADRA1D has been implicated in conditions like hypertension and its potential role in cardiovascular diseases. Oct 14 2022

    chat Jessica (Verified Customer)

    Can ADRA1D be used as a therapeutic target? Sep 26 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    While ADRA1D is being studied for its potential role in various conditions, it's essential to understand its function fully before considering it as a therapeutic target. Sep 26 2021

    Published Data

    Fig.1 The effects of Adra1d inhibition on myoblast survival.

    After pre-treatment with Adra1d siRNA or Negative siRNA control for 24 hours, GM myoblasts were shifted into differentiation medium. They were subsequently exposed to 1.5 ng/ml IGF-I or co-cultured with 1.25ng/ml and 1.5 ng/ml IGF-I, following a prior administration of a 20 μM MAPK inhibitory agent (PD98059). The myoblasts were stained with trypan blue, and cell damage was assessed as the percentage of cell death, based on data from three independent experiments conducted in duplicate.

    Ref: Saini, Amarjit, Nasser Al-Shanti, and Claire Stewart. "C2 skeletal myoblast survival, death, proliferation and differentiation: regulation by Adra1d." Cellular Physiology and Biochemistry 25.2-3 (2010): 253-262.

    Pubmed: 20110686

    DOI: 10.1159/000276559

    Research Highlights

    Wang J, et al. "Functional Involvement of ADRA1D in Cutaneous Melanoma Progression and ." Cellular and molecular biology (Noisy-le-Grand, France), 2023.
    Cutaneous melanoma is a highly aggressive and malignant skin cancer that poses a significant challenge in treating advanced-stage patients due to its high recurrence rate and drug resistance. A study investigated the potential of targeting the alpha-1 adrenergic receptor (ADRA1) subtypes as a treatment for melanoma in mice, but the role of the alpha-1D subtype (ADRA1D) in this cancer remains unclear. Using tissue samples and experiments on cells, researchers found that ADRA1D was expressed at low levels in cutaneous melanoma and its overexpression inhibited the growth, invasion, and proliferation of melanoma cells while also reducing angiogenesis in vivo. These findings suggest that ADRA1D may serve as a promising target in the treatment of cutaneous melanoma by regulating the HIF-1alpha/VEGF axis and inhibiting tumor growth and metastasis.
    Pubmed: 37571902   DOI: 10.14715/cmb/2023.69.5.8

    Zhou H, et al. "Chronic unpredictable stress induces depression/anxiety-related behaviors and ." Heliyon, 2023.
    Depression and anxiety are widely recognized as the most prevalent mental health disorders, impacting individuals of all ages and disproportionately affecting females. However, despite its prevalence, the underlying pathophysiological changes associated with these disorders are not well understood. In the present study, the effects of age and stress on depression- and anxiety-related behaviors in female mice were evaluated. Specifically, saccharin preference and the open field test were utilized before and after exposure to chronic unpredictable stress in mice at 4, 14, and 25 months of age. Following behavioral testing, mRNA levels of monoamine receptors in the hippocampus were measured using real-time RT-PCR. The results indicated that chronic unpredictable stress significantly decreased saccharin preference in all age groups studied, as well as time spent in the center of the open field test in 25-month-old mice. Additionally, age and stress were found to significantly impact the expression of specific monoamine receptors, with correlations observed between saccharin preference and select receptor levels in 4-month-old mice, and between time spent in the center of the open field test and receptor levels in 4 and 14-month-old mice. These findings suggest that stress has a significant impact on both depressive and anxious behaviors, as well as the expression of monoamine receptors in the hippocampus, in a manner that is dependent on an individual's age.
    Pubmed: 37539192   DOI: 10.1016/j.heliyon.2023.e18369

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare